Search
Take a look back at some of the year’s biggest news in cancer research.
Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth.
Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
During meiosis, small chromosomes risk being lost in the shuffle. Here’s how they hold their own.
As construction began on the Mortimer B. Zuckerman Research Center, SKI adopted new ways to advance therapeutic innovation at Memorial Sloan Kettering.
MSK researchers shed light on the signals that determine the fate of embryonic cells.
Nanoparticles were thought of a silent partner in imaging technologies. They’re now being recognized as an important source of subatomic chatter.
The study represents 20 years of research at MSK.
Learn about the eight students who successfully defended their dissertations and will be awarded PhD degrees during the Gerstner Sloan Kettering Graduate School of Biomedical Sciences commencement ceremony on May 27.